LOX and neoplasm: Thus, the reduction of whole body tumor burden in mice pre-treated (day −1) with BAPN was likely a result of LOX inhibition during the initial steps of tumor cell interaction with the blood vessel epithelium; while the effect of BAPN in the ‘day 0’ group may have been due LOX inhibition during the later stages of extravasation and initial tissue colonization.